. Author manuscript; available in PMC: 2021 Oct 19.

Published in final edited form as: J Pediatr Gastroenterol Nutr. 2019 Sep;69(3):339–343. doi: 10.1097/MPG.0000000000002401

TABLE 1.

Differences in demographic and clinical characteristics between those who were and those who were not on psychotropic medications at the time of the liver biopsy

Variable	No psychotropic medications (n=211)	Receiving psychotropic medications (n=17)	P
Age	14 (2–21)	15 (8–17)	0.82
Sex; n (% male)	136 (65%)	13 (76%)	0.33
Ethnicity			0.61
N (%) Hispanic	45 (21%)	2 (12%)
N (%) non-Hispanic	164 (78%)	15 (88%)
Obesity categories
Overweight; n (%)	6 (3%)	0 (0%)	0.48
Class I obesity; n (%)	42 (20%)	2 (12%)	0.41
Class II obesity; n (%)	67 (32%)	5 (29%)	0.84
Class III obesity; n (%)	93 (44%)	9 (53%)	0.48
Unknown; n (%)	3 (1%)	1 (6%)
Body mass index, kg/m²	36 (31–40)	36 (35–42)	0.36
Type 2 diabetes mellitus n(%)	19(9%)	3 (18%)	0.25
Other treatments
Vitamin E; n (%)	9 (4%)	0 (0%)	0.38
Metformin; n (%)	55 (26%)	9 (53%)	0.02
Statins; n (%)	2 (1%)	0 (0%)	0.69
Anti-HTN drugs; n (%)	16 (8%)	5 (29%)	0.01

Data are presented as medians (ranges) unless otherwise indicated.

HTN = hypertension.